Capital Flow Monitor · Sponsors · CIK 2135703
Rubicon Founders Ivy Fund, LP
C/O RUBICON FOUNDERS LLC, NASHVILLE, TN, 37208 · (615) 864-0524
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | D ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- n/a Rubicon Founders OP GP, LP — Promoter, Nashville, TN
-
n/a Rubicon Founders LLC — Executive Officer, Nashville, TN
1 other raise
- Rubicon Fund II LP $1.12B of —
-
Adam Boehler — Executive Officer, Nashville, TN
1 other raise
- Rubicon Fund II LP $1.12B of —
-
Austin Smith — Executive Officer, Nashville, TN
2 other raises
- LASTpatient Inc. $400K of $1.0M · 40.0%
- Rubicon Fund II LP $1.12B of —
-
David Glaccum — Executive Officer, Nashville, TN
1 other raise
- Atlas Oncology Holdings Inc. $23.0M of $23.0M · 100.0%
-
Todd Nice — Executive Officer, Nashville, TN
2 other raises
- Atlas Oncology Holdings Inc. $23.0M of $23.0M · 100.0%
- Rubicon Fund II LP $1.12B of —
-
Cory Reno — Executive Officer, Nashville, TN
1 other raise
- Rubicon Fund II LP $1.12B of —
-
Elise Morrissey — Executive Officer, Nashville, TN
1 other raise
- Rubicon Fund II LP $1.12B of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.